Q&A

Driving Precision, Agility, And Partnership In Complex Drug Development

GettyImages-1371925389-lab-scientist-collaboration-computer-clipboard

The field of pharmaceutical development has changed dramatically with the emergence of targeted therapies, complex biologics, and ultra-potent small molecules. Today, it's more integrated into the drug development process, requiring condensed timelines and technical agility across various drug delivery formats and therapeutic areas.

Anshul Gupte, PhD, Vice President of Pharmaceutical Development at PCI Pharma Services, discusses a range of topics, including phase-appropriate development, technical challenges in pharmaceutical science, building agile teams, and key strategies for sponsors to consider when developing new therapies.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

PCI Pharma Services